The largest database of trusted experimental protocols

In cell 2000 analyzer bioimaging system

Manufactured by GE Healthcare
Sourced in United States

The IN Cell 2000 Analyzer Bioimaging System is a high-content screening platform designed for automated cellular imaging and analysis. The system utilizes fluorescence microscopy to capture images of cells and cellular structures, enabling researchers to study a range of biological processes and cellular responses.

Automatically generated - may contain errors

2 protocols using in cell 2000 analyzer bioimaging system

1

Cytotoxicity Evaluation of Compounds 5A, 5D, and 5E

Check if the same lab product or an alternative is used in the 5 most similar protocols
The potential cytotoxicity of 5A was tested by alamarBlueTM Cell Viability Assay (Thermo Fisher Scientific, Waltham, MA, USA) as previously described [18 (link)]. Briefly, 1 × 106/mL rhesus monkey kidney epithelial cells (LLC-MK2), and 1 × 106/mL BALB/c IPФ were seeded in a 96-well clear bottom black microplate (BD Biosciences, Franklin Lakes, NJ, USA). Cells were incubated in the presence of increasing drug concentrations for 72 h (LLC-MK2) or 48 h (IPФ) at 37 °C, 5% CO2, followed by addition of alamarBlueTM. Fluorescence was measured using a fluorometer (Fluoroskan; Thermo Fisher Scientific, Waltham, MA, USA). Compound 5D or 5E were incubated with 1 × 105 cells/mL (LLC-MK and IPФ) for 72 or 48 h, respectively, at 37 °C, 5% CO2. After the incubation period, a dilution of 20:1000 in PBS from a stock at 1 mg/mL of Propidium Iodide (PI) and Hoechst 33342 (Thermo Scientific, Waltham, MA, USA) were added for survival discrimination as previously described [44 (link)]. Analysis was performed by High-Content Imaging Assay (HCIA) using an IN Cell 2000 Analyzer Bioimaging System (GE Healthcare, Chicago, IL, USA) for LLC-MK2 cells, and BD Pathway 855 High-resolution Bioimager System (BD Biosciences, Franklin Lakes, NJ, USA) for IPФ. The 50% cytotoxic concentration (CC50) and selective index (S.I.) was determined and summarized in Table 1.
+ Open protocol
+ Expand
2

Evaluating Antileishmanial Efficacy of Novel Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
BALB/c IPФ were acquired and seeded at a density of 1 × 105 cells/mL for 2 h at 37 °C, 5% CO2. After adherence, IPФ were infected with 1 × 106/mL metacyclic promastigotes of L. major-luc, at a ratio of 10:1 parasites per macrophage. Subsequently, infected IPФ were incubated with derivatives 5A, 5D and 5E at increasing concentrations (0.625 to 10 µM) for 48 h treatment. Afterwards, cells were fixed with 4% paraformaldehyde, and stained with (1.25:100) Alexa Fluor™ 488 Phalloidin (Thermo Fisher Scientific, Waltham, MA, USA) and (1:1000) DAPI (Sigma Aldrich, St. Louis, MO, USA). Then, the numbers of infected cells and amastigotes were determined by HCIA using an IN Cell 2000 Analyzer Bioimaging System (GE Healthcare, Chicago, IL, USA). Parameters were set for the excitation and emission spectra of Alexa Fluor™ 488 Phalloidin and DAPI, and a constraint of 3 or more parasites per macrophage was set as previously reported [44 (link),45 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!